Nido Biosciences

Acquisition, funding and merger involving Nido Biosciences.

• Nido Biosciences has just announced a $109 Million fundraising (posted on May 19 2023).

View the org chart displaying its 11 main executives

Most searched biographies at Nido Biosciences

• Jeremy Springhorn, Chief Executive Officer and Director
• Deborah Palestrant, Director
• Mike Clayman, Chairman of the Board

Create your alert
to follow the executive moves at Nido Biosciences.

Nido Biosciences has 2,294 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Nido Biosciences

Social media about Nido Biosciences

• Nido Biosciences on Wikipedia, Google News & Yahoo Finance
• Nido Biosciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Jeremy Springhorn

Call Nido Biosciences at +1 781...

View the org chart

Register to receive your alert

Report an error